Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Liver Cirrhosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Liver Cirrhosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Cirrhosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
158 pages
Osteosarcoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Osteosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Osteosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
868 pages
Anal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Anal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
589 pages
Bronchopulmonary Dysplasia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Bronchopulmonary Dysplasia (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchopulmonary Dysplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
81 pages
Restenosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Restenosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Restenosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
39 pages
Pulmonary Embolism - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Pulmonary Embolism (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Pulmonary Embolism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
56 pages
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Spinal Muscular Atrophy (SMA) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
August 2020
164 pages
Burns - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Burns (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Burns and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
111 pages
Pruritus - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Pruritus (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
206 pages
Candidiasis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Candidiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Candidiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
225 pages
Cough - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cough (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
116 pages
Diabetic Nephropathy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Diabetic Nephropathy (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Nephropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
269 pages
Ocular Hypertension - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ocular Hypertension (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Ocular Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
145 pages
Oral Mucositis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Oral Mucositis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Oral Mucositis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
66 pages
Polycythemia Vera - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Polycythemia Vera (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Polycythemia Vera and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
132 pages
Blepharitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Blepharitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Blepharitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
63 pages
Fabry Disease - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Fabry Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fabry Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
126 pages
Grass Pollen Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Grass Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Grass Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
80 pages
Seborrhea - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Seborrhea (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Seborrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
50 pages
Diabetic Gastroparesis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Diabetic Gastroparesis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Diabetic Gastroparesis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
68 pages
Myocardial Ischemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Myocardial Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
90 pages
Nasopharyngeal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Nasopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Nasopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
854 pages
Primary Immune Deficiency (PID) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Primary Immune Deficiency (PID) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Primary Immune Deficiency (PID) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
134 pages
Rectal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Rectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
245 pages
Cat Allergy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cat Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Cat Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
31 pages
Dementia - Pipeline Review, H2 2020
US$ 2,000.00
... . The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
537 pages
Thalassemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Thalassemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thalassemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
215 pages
Leiomyosarcoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Leiomyosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Leiomyosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
642 pages
Drug Addiction - Pipeline Review, H2 2020
US$ 2,000.00
... . The Drug Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Drug Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
216 pages
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The B-Cell Chronic Lymphocytic Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for B-Cell Chronic Lymphocytic Leukemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
211 pages
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
631 pages
Viral Conjunctivitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Viral Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Viral Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
52 pages
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2020
US$ 2,000.00
... Juvenile Macular Degeneration (Stargardt Disease) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Juvenile Macular Degeneration (Stargardt Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
104 pages
Batten Disease - Pipeline Review, H2 2020
US$ 2,000.00
... . The Batten Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Batten Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
93 pages
African Trypanosomiasis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The African Trypanosomiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for African Trypanosomiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
68 pages
Arrhythmias - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Arrhythmias (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arrhythmias and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
86 pages
Encephalomyelitis - Pipeline Review, H2 2020
US$ 2,000.00
... . The Encephalomyelitis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalomyelitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
62 pages
Periodontitis - Pipeline Review, H2 2020
US$ 2,000.00
... And Dental Disorders) pipeline guide also reviews of key players involved in therapeutic development for Periodontitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
57 pages
Gonorrhea - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Gonorrhea (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Gonorrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
130 pages
Myocarditis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Myocarditis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocarditis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
50 pages
Cryptococcosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Cryptococcosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cryptococcosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
59 pages
Becker Muscular Dystrophy - Pipeline Review, H2 2020
US$ 2,000.00
... . The Becker Muscular Dystrophy (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Becker Muscular Dystrophy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
95 pages
Fibrosarcoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Fibrosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Fibrosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
134 pages
Meniere Disease - Pipeline Review, H2 2020
US$ 2,000.00
... . The Meniere Disease (Ear Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Meniere Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...
August 2020
48 pages
Optic Neuropathy - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Optic Neuropathy (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Optic Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
73 pages
Synovial Sarcoma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Synovial Sarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Synovial Sarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
August 2020
419 pages
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2020
US$ 2,000.00
... The Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and features dormant and discontinued projects. The guide covers therapeutics under ...
August 2020
78 pages
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Crohn’s Disease (Regional Enteritis) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Crohn’s Disease (Regional Enteritis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
693 pages
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2020
US$ 2,000.00
... latest pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) Number of Products under Development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma ...
August 2020
1084 pages
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Severe Acute Respiratory Syndrome (SARS) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
August 2020
152 pages
